Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys

Citation
Er. Butelman et al., Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys, EUR J PHARM, 383(3), 1999, pp. 305-309
Citations number
20
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
383
Issue
3
Year of publication
1999
Pages
305 - 309
Database
ISI
SICI code
0014-2999(19991103)383:3<305:AEOKRL>2.0.ZU;2-6
Abstract
These studies investigated whether serum prolactin levels could be a quanti tative marker of the apparent efficacy of K-opioid receptor ligands in prim ates. The effects of s.c. bremazocine and U50,488 (trans-(+/-)-3,4-Dichloro -N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamide; agonists), na lorphine (partial agonist) and nalmefene (antagonist) on prolactin levels w ere studied in intact female rhesus monkeys. The above compounds, except na lmefene, increased prolactin levels, and their actions conformed to sigmoid al dose-effect curves. The rank order of the compounds' maximum effects in this neuroendocrine endpoint is similar to that in cloned K-receptors in vi tro, and in a presently studied thermal antinociception assay in vivo. Prol actin may therefore be a quantitative marker of the apparent efficacy of K- opioid receptor ligands in primates. (C) 1999 Elsevier Science B.V. All rig hts reserved.